CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The OPTObacteria project focuses on developing an Automatic Laboratory Detector (ALD) that significantly reduces the time required for diagnosing bacterial infections and detecting drug resistance. By utilizing optical fiber technology, it aims to provide rapid results, enhancing the efficiency of microbial diagnostics…
Infectious disease are responsible of high human health burden and cost.
Time to diagnosis release and quality of the microrganism detection represent an area of interest for optical fiber based device application.OPTObacteria propose an highly expert consortium in which 4 SME and 4 research peformers from 3 European countries would synergize their efforts to provide a unique Automatic Laboratory Detector (ALD) to deliver a drug resistance report in a 4 or 4-8 hours timeframe.
The time is depend…
TYDOCK PHARMA S.r.l
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
United Kingdom, London
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Italy, NAPOLI
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Italy, Modena
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
